SH3PXD2A-OBFC1 Fusion FISH Probe
The SH3PXD2A-OBFC1 Fusion FISH Probe is used to confirm a fusion of the SH3PXD2A and OBFC1 genes. The fusion of the SH3PXD2A and OBFC1 genes has been associated with Lung Squamous Cell Carcinoma, Lung Adenocarcinoma, Head And Neck Squamous Cell Carcinoma , Breast Invasive Carcinoma, Head And Neck Squamous Cell Carcinoma , Bladder Urothelial Carcinoma, Cervical Squamous Cell Carcinoma And Endocervical Adenocarcinoma, Esophageal Carcinoma, Esophageal Carcinoma, Bladder Urothelial Carcinoma, and Stomach Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| SH3PXD2A-OBFC1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| SH3PXD2A-OBFC1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| SH3PXD2A-OBFC1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| SH3PXD2A-OBFC1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| SH3PXD2A-OBFC1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| SH3PXD2A-OBFC1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| SH3PXD2A-OBFC1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| SH3PXD2A-OBFC1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| SH3PXD2A-OBFC1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| SH3PXD2A-OBFC1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| SH3PXD2A-OBFC1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| SH3PXD2A-OBFC1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| SH3PXD2A-OBFC1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| SH3PXD2A-OBFC1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| SH3PXD2A-OBFC1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| SH3PXD2A-OBFC1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| SH3PXD2A-OBFC1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| SH3PXD2A-OBFC1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| SH3PXD2A-OBFC1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| SH3PXD2A-OBFC1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| SH3PXD2A-OBFC1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| SH3PXD2A-OBFC1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| SH3PXD2A-OBFC1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| SH3PXD2A-OBFC1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| SH3PXD2A-OBFC1-20-AQAQ | 20 (40 μL) | 200 μL |
|
SH3PXD2A Gene Summary
The SH3 And PX Domains 2A (SH3PXD2A) gene is located on chr10 :105353783-105615164 at 10q24.33.
Gene Name: SH3 And PX Domains 2A
Chromosome: CHR10: 105353783 -105615164
Locus: 10q24.33
Gene Diseases
The SH3PXD2A OBFC1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Lung Squamous Cell Carcinoma |
| Lung Adenocarcinoma |
| Head And Neck Squamous Cell Carcinoma |
| Breast Invasive Carcinoma |
| Head And Neck Squamous Cell Carcinoma |
| Bladder Urothelial Carcinoma |
| Cervical Squamous Cell Carcinoma And Endocervical Adenocarcinoma |
| Esophageal Carcinoma |
| Esophageal Carcinoma |
| Bladder Urothelial Carcinoma |
| Stomach Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|